Mj. Evans et al., IS THERE AN ASSOCIATION BETWEEN LONG-TERM TAMOXIFEN TREATMENT AND THEDEVELOPMENT OF CARCINOSARCOMA (MALIGNANT MIXED MULLERIAN TUMOR) OF THE UTERUS, International journal of gynecological cancer, 5(4), 1995, pp. 310-313
A cluster of five patients with endometrial carcinosarcoma (malignant
mixed Mullerian tumor) occurred at our center during 1993; four of the
se had been prescribed long-term tamoxifen for breast carcinoma. Searc
hing the archives for the 9-year period 1983-1992 revealed two further
cases of uterine carcinosarcoma occurring in patients prescribed tamo
xifen, from a total of 16 cases of this tumor. Five of the six patient
s diagnosed with carcinosarcoma who had been taking tamoxifen had been
maintained on the drug for at least 6 years, while the other had a 3-
year history of tamoxifen therapy. From these data we raise the questi
on of an association between long-term tamoxifen treatment and develop
ment of endometrial carcinosarcoma, following the dramatic increase in
the prescribing of this drug after 1984.